Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher Porter

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
The Journal of Biological Chemistry|October 23, 2012
Nontruncating SCN1A mutations associated with severe myoclonic epilepsy of infancy impair cell surface expressionChristopher H Thompson, J Christopher Porter, Kristopher M Kahlig, et al.
World Journal of Urology|August 6, 2022
The role of multiparametric ultrasound in the detection of clinically significant prostate cancerNathan Jung, Renzo G DiNatale, Jason Frankel, et al.
Urologic Oncology|October 1, 2022
Impact of COVID-19 on Society of Urologic Oncology fellowship operative volumesAdam M Daily, Hannah G Koenig, Eyal Kord, et al.
Prostate Cancer|November 19, 2011
Racial/Ethnic patterns in prostate cancer outcomes in an active surveillance cohortJennifer Cullen, Stephen A Brassell, Yongmei Chen, et al.
The Journal of Molecular Diagnostics : JMD|January 12, 2016
Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early RecurrenceXiaoyu Qu, Claudio Jeldres, Lena Glaskova, et al.
Urologic Oncology|March 14, 2023
Are high-risk prostate cancer patients being treated equally? The impact of PSAEyal Kord, Basil Ferenczi, Renzo G DiNatale, et al.
Urologic Oncology|June 16, 2014
Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancerAdam R Metwalli, Inger L Rosner, Jennifer Cullen, et al.
Cancer Genetics|January 29, 2013
A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancerXiaoyu Qu, Grace Randhawa, Cynthia Friedman, et al.
Plos One|October 8, 2013
A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumorsXiaoyu Qu, Grace Randhawa, Cynthia Friedman, et al.
Molecular Cancer Research : MCR|March 16, 2013
PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortalityEric G Bluemn, Elysia Sophie Spencer, Brigham Mecham, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
The Journal of Biological Chemistry|October 23, 2012
Nontruncating SCN1A mutations associated with severe myoclonic epilepsy of infancy impair cell surface expressionChristopher H Thompson, J Christopher Porter, Kristopher M Kahlig, et al.
World Journal of Urology|August 6, 2022
The role of multiparametric ultrasound in the detection of clinically significant prostate cancerNathan Jung, Renzo G DiNatale, Jason Frankel, et al.
Urologic Oncology|October 1, 2022
Impact of COVID-19 on Society of Urologic Oncology fellowship operative volumesAdam M Daily, Hannah G Koenig, Eyal Kord, et al.
Prostate Cancer|November 19, 2011
Racial/Ethnic patterns in prostate cancer outcomes in an active surveillance cohortJennifer Cullen, Stephen A Brassell, Yongmei Chen, et al.
The Journal of Molecular Diagnostics : JMD|January 12, 2016
Identification of Combinatorial Genomic Abnormalities Associated with Prostate Cancer Early RecurrenceXiaoyu Qu, Claudio Jeldres, Lena Glaskova, et al.
Urologic Oncology|March 14, 2023
Are high-risk prostate cancer patients being treated equally? The impact of PSAEyal Kord, Basil Ferenczi, Renzo G DiNatale, et al.
Urologic Oncology|June 16, 2014
Elevated alkaline phosphatase velocity strongly predicts overall survival and the risk of bone metastases in castrate-resistant prostate cancerAdam R Metwalli, Inger L Rosner, Jennifer Cullen, et al.
Cancer Genetics|January 29, 2013
A novel four-color fluorescence in situ hybridization assay for the detection of TMPRSS2 and ERG rearrangements in prostate cancerXiaoyu Qu, Grace Randhawa, Cynthia Friedman, et al.
Plos One|October 8, 2013
A three-marker FISH panel detects more genetic aberrations of AR, PTEN and TMPRSS2/ERG in castration-resistant or metastatic prostate cancers than in primary prostate tumorsXiaoyu Qu, Grace Randhawa, Cynthia Friedman, et al.
Molecular Cancer Research : MCR|March 16, 2013
PPP2R2C loss promotes castration-resistance and is associated with increased prostate cancer-specific mortalityEric G Bluemn, Elysia Sophie Spencer, Brigham Mecham, et al.
Pageof 4